Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-FR
Language English French
Date Updated 2018-04-04 2018-04-04
Drug Identification Number 02431548 02431548
Brand name METHYLENE BLUE INJECTION METHYLENE BLUE INJECTION
Common or Proper name Methylene Blue Injection Methylene Blue Injection
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients METHYLENE BLUE METHYLENE BLUE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 ML 5 ML
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Shortage of an active ingredient. Other (Please describe in comments)
Anticipated start date
Actual start date 2018-03-31 2018-03-31
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Long term backorder; global API shortage Long term backorder; global API shortage
Health Canada comments